Burden of Central Nervous System Cancer in the United States, 1990-2021
JAMA Neurology · 01.01.2026 · 83 (1) · 35
DOI: 10.1001/jamaneurol.2025.4286 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Neurology, erschienen am 01.01.2026. Verfasst von GBD 2021 US CNS Cancer Collaborators und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Yonsei University, Seoul, South Korea. Hauptthemen laut MEDLINE: Central Nervous System Neoplasms, Cost of Illness. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Primary brain and central nervous system cancer (collectively referred to as CNS cancer) comprises 2% of all human cancers and poses significant health and economic challenges in the United States.
Objective
To analyze CNS cancer burden in the US, stratified by time, location (state and division), sex, age group, and Sociodemographic Index (SDI). Design, Setting, and Participants This cross-sectional study involved a repeated analysis of Global Burden of Disease Study (GBD) 2021 data in 2024. Using data from 183 sources, CNS cancer metrics in the US were estimated across states and years. US CNS cancer metrics across all sexes and age groups were included in the GBD. Exposure CNS cancer diagnosis. Main Outcomes and Measures Overall and age-standardized estimates of the incidence, prevalence, mortality, disability-adjusted life-years (DALYs), years of life lost, and years lived with disability per 100 000 population, including 95% uncertainty intervals (UIs), and time trends.
Results
In 2021, for all age groups and sexes across the US, there were 31 780 incident cases (95% UI, 29971.1 to 32843.9). Age-standardized incidence, DALYs, and mortality rates per 100 000 population were 6.91 (95% UI, 6.58 to 7.12), 134.38 (95% UI, 129.83 to 137.95), and 4.1 (95% UI, 3.87 to 4.22), respectively. Despite no significant change observed in the overall incidence between 1990 and 2021, DALY and mortality rates decreased by 15.77% (95% UI, −17.75% to −13.68%) and 8.41% (95% UI, −11.09% to −6.22%), respectively. Substantial geographic variability was noted. Mississippi, Alabama, Kentucky, and Kansas (West North Central and East South Central divisions) and West Virginia faced persistently high burdens over the past 30 years. Sex differences were evident; disease burden was consistently higher in males compared with females. Age-specific estimates showed a bimodal distribution: the youngest group (<5 years) showed a significant decrease in incidence rate (−34.42% to −11.56%), whereas older age groups (>70 years) experienced increasing trends. DALYs and mortality rates were negatively correlated with SDI (ρ = −0.6860 and ρ = −0.6391; P < .001). Conclusions and Relevance These findings provide valuable insights into the CNS cancer burden across the US by age, sex, location, and SDI, enabling better public health status assessments, health care policy restructuring, and resource redistribution for improved care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Neurosurgery, Yonsei University, Seoul, South Korea.
- Department of Medicine, Yonsei University, Seoul, South Korea.
- Department of Biomedical Data Science, Stanford University, Stanford, California.
- Department of Pediatrics, Yonsei University College of Medicine, Seoul, South Korea.
- Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
- Massachusetts General Hospital, Boston.
Zitieren
APA
GBD 2021 US CNS Cancer Collaborators, Han, H. J., Kim, Y. S., Park, S., Shin, J. I., Kim, M. S., Moon, J. H., Kim, Y. B., Ababneh, H. S., Abu-Zaid, A., Areda, D., Arul, S., Azzam, A. Y., Bardhan, M., Bayat Tork, M. A., Behnam, B., Bilgin, G. B., Bhardwaj, P. V., Bhuyan, S. S., …, & Sabet, C. J. (2026). Burden of Central Nervous System Cancer in the United States, 1990-2021. JAMA Neurology, 83(1), 35. https://doi.org/10.1001/jamaneurol.2025.4286
Vancouver
GBD 2021 US CNS Cancer Collaborators, Han HJ, Kim YS, Park S, Shin JI, Kim MS, et al. Burden of Central Nervous System Cancer in the United States, 1990-2021. JAMA Neurology. 2026;83(1):35. doi:10.1001/jamaneurol.2025.4286
BibTeX
@article{GBDUSCNSCancerCollaborators2026,
author = {GBD 2021 US CNS Cancer Collaborators, GBD 2021 US CNS Cancer Collaborators and Han, Hyun Jin and Kim, Yun Seo and Park, Seoyeon and Shin, Jae Il and Kim, Min Seo and Moon, Ju Hyung and Kim, Yong Bae and Ababneh, Hazim S and Abu-Zaid, Ahmed and Areda, Demelash and Arul, Santhosh and Azzam, Ahmed Y and Bardhan, Mainak and Bayat Tork, Mohammad Amin and Behnam, Babak and Bilgin, Gokce Belge and Bhardwaj, Prarthna V and Bhuyan, Soumitra S and Lomer, Nima Broomand and Chen, Meng Xuan and Chennapragada, Suma Sri and Dai, Xiaochen and Dean, Frances E and Deekonda, Sindhura and Ding, Xueting and Doshi, Ojas Prakashbhai and E'mar, Abdel Rahman and Elhadi, Muhammed and Fares, Jawad and Fazeli, Patrick and Fisher, James L and Fotouhi, Maryam and Gholamrezanezhad, Ali and Ida, Fidelia and Iwu, Chidozie Declan and Jalloh, Mohamed and Jani, Chinmay T and Kalani, Rizwan and Kankam, Samuel Berchi and Kazemi, Foad and Keshwani, Ariz and Khosla, Atulya Aman and Lim, Stephen S and Mehboob, Riffat and Mestrovic, Tomislav and Mokdad, Ali H and Murray, Christopher J L and Naik, Gurudatta and Natto, Zuhair S and Nguyen, Dang and Nugen, Fred and Orscelik, Atakan and Parikh, Romil R and Penberthy, Louise and Pestell, Richard G and Prabhu, Disha and Puvvula, Jagadeesh and Ramasamy, Shakthi Kumaran and Sabet, Cameron John},
title = {Burden of Central Nervous System Cancer in the United States, 1990-2021},
journal = {JAMA Neurology},
year = {2026},
volume = {83},
number = {1},
pages = {35},
doi = {10.1001/jamaneurol.2025.4286}
}
EUVIMED